Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
Bupicaine hydrochloride (+) |
EINECS | N/A |
CAS No. | 27262-46-0 | Density | g/cm3 |
PSA | 32.34000 | LogP | 4.70940 |
Solubility | N/A | Melting Point |
258 °C |
Formula | C18H28 N2 O . Cl H | Boiling Point | 423.4°Cat760mmHg |
Molecular Weight | 324.894 | Flash Point | 209.9°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, subcutaneous, intravenous, parenteral, and intratracheal routes. When heated to decomposition it emits very toxic fumes of HCl and NOx. See other bupicaine or bupivacaine entries. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
2-Piperidinecarboxamide,1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride, (2R)- (9CI);2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride,(R)-; 2',6'-Pipecoloxylidide, 1-butyl-, monohydrochloride, (+)- (8CI);(+)-Bupivacaine monohydrochloride; (R)-(+)-Bupivacaine monohydrochloride |
Article Data | 5 |
IUPAC Name: (2R)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride
Synonyms of Bupicaine hydrochloride (+) (CAS NO.27262-46-0): (+)-Bupicaine HCl ; 2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride, (+)-
InChI: InChI=1/C18H28N2O.ClH/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3;/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21);1H/t16-;/m1./s1
InChIKey: SIEYLFHKZGLBNX-PKLMIRHRBT
Std. InChI: InChI=1S/C18H28N2O.ClH/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3;/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21);1H/t16-;/m1./s1
Std. InChIKey: SIEYLFHKZGLBNX-PKLMIRHRSA-N
CAS NO: 27262-46-0
Molecular Formula: C18H29ClN2O
Molecular Weight: 324.8887
Molecular Structure :
H bond acceptors: 3
H bond donors: 1
Freely Rotating Bonds: 5
Polar Surface Area: 23.55 Å2
Flash Point: 209.9 °C
Enthalpy of Vaporization: 67.78 kJ/mol
Boiling Point: 423.4 °C at 760 mmHg
Vapour Pressure: 2.24E-07 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intravenous | 7200ug/kg (7.2mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 200, Pg. 359, 1972. | |
mouse | LD50 | subcutaneous | 58mg/kg (58mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 200, Pg. 359, 1972. | |
rabbit | LD50 | intratracheal | 12mg/kg (12mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 200, Pg. 359, 1972. | |
rabbit | LD50 | intravenous | 3300ug/kg (3.3mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 200, Pg. 359, 1972. | |
rabbit | LD50 | oral | 18mg/kg (18mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 200, Pg. 359, 1972. | |
rabbit | LD50 | parenteral | 185mg/kg (185mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 200, Pg. 359, 1972. | |
rat | LD50 | intravenous | 6mg/kg (6mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 200, Pg. 359, 1972. | |
rat | LD50 | subcutaneous | 43mg/kg (43mg/kg) | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 200, Pg. 359, 1972. |
Poison by ingestion, subcutaneous, intravenous, parenteral, and intratracheal routes. When Bupicaine hydrochloride (+) (CAS NO.27262-46-0) is heated to decomposition, it emits very toxic fumes of HCl and NOx. See other bupicaine or bupivacaine entries.